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Abstract
Psychoneuroimmunoendocrinology, which was first described in 1936, is the study of the interactions between the
psyche, neural and endocrine functions and immune responses. The aim of psychoneuroimmunoendocrinology is
to apply medical knowledge to the treatment of different allergic, immune, autoimmune, rheumatic, neoplastic,
endocrine, cardiovascular and dental pathologies, among other disorders. Epigenetic factors and major stresses
from different types of stimuli acting through distinct pathways and neurotransmitters are highly involved in
altering the psychoneuroimmunoendocrine axis, resulting in the emergence of disease. The main purpose of this
report is to expand the understanding of psychoneuroimmunoendocrinology and to demonstrate the importance
of the above-mentioned interactions in the etiology of multiple pathologies. In this review, a search of the medical
literature using PubMed (free access search engine for the Medline database of the National Library of Medicine of
the United States) over the years 1936 to 2016 was conducted, and descriptive and experimental studies and
reviews of the scientific literature were included.
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Background
Each field of medicine has a defined scope; however, inter-
actions between systems covered by different fields exist.
A link between findings from psychiatry, neurology, im-
munology and endocrinology has been noted for many
years. From the functional, anatomical and physiological
perspectives, the correlation between the central nervous
system (CNS) and the endocrine system is complex and
involves several actors, such as cytokines, receptors and
neurotransmitters. The immune system is connected to
the endocrine and neural systems via a number of path-
ways that integrate the functions of the hypothalamus, pi-
tuitary glands, adrenal glands, thyroid glands, gonads and
autonomic nervous system. Major clinical implications
and a vast amount of pathologies are related to the rela-
tionships between the systems covered by the science of
psychoneuroimmunoendocrinology.
Many studies have described the negative effects of
stress on health. Ader and Cohen in 1975 studied
the effects of stress on the immune system. These
previous findings are currently accepted, and a new
area of study focusing on inflammation, autoimmun-
ity and secondary hypersensitivity to stress has been
developed.
Neuroimmunophysiologists have found that stress,
anxiety and depression not only affect the protective
function of the immune system but also alter its regula-
tory function.
Socioeconomic status as well as chronic illnesses such
as autoimmune and rheumatic diseases, asthma, allergic
rhinitis, atopic dermatitis, urticaria, cardiovascular dis-
ease, hypertension and diabetes mellitus affect mood by
generating stress, anxiety and depression, all of which
negatively influence immune system function and regu-
lation. For example, asthma was historically referred to
as “nervous asthma” in relation to living with a histrionic
mother, and atopic dermatitis was referred to as
“neurodermatitis.”
This review seeks to gather knowledge and the
main clinical implications from the field of
psychoneuroimmunoendocrinology.
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Psychoneuroimmunoendocrinology
Psychoneuroimmunoendocrinology is the study of the
interaction between the psyche, neural function, endo-
crine function and immune responses. These systems
can interact through two pathways: changes in neural
and endocrine functions that alter immune responses or
stimulation of immune responses that modify the func-
tionality of the endocrine system and the CNS. Behav-
ioral processes are able to initiate both pathways, which
leads to altered behavior in an individual [1]. Interac-
tions between these various systems regulate a variety of
physiological processes, and their normal interaction
helps to reduce the vulnerability of individuals to certain
diseases [2, 3]. One aim of psychoneuroimmunoendocri-
nology is to apply medical knowledge to different psy-
chological disorders (e.g., depression), neurological
conditions (e.g., dementia), immune disorders (e.g., auto-
immune diseases) and neoplastic diseases [4].
Background and origin of
psychoneuroimmunoendocrinology
The theory of “general adaptation syndrome” proposed
in 1936 relates stress with cortico-adrenal secretion and
accounts for the protective effects of adrenal extracts on
stress [5]. Subsequently, Solomon et al., introduced a
“speculative theory”, later known as psychoimmunology,
and following the introduction of this theory, Ader and
Cohen published their work on classical conditioning of
immune functions entitled “Behavioral conditioning of
immunosuppression”, in which they proposed a func-
tional link between the immune system and the nervous
system such that the immune response generates cyto-
kines that stimulate the CNS [6, 7]. This stimulation of
the brain activates the hypothalamic-pituitary-adrenal
axis, which in turn suppresses the immune response
through the secretion of glucocorticoids [8]. Accumulat-
ing evidence since 1980 has established the mechanism
by which thoughts, emotions and behavior modulate
and mediate endocrine and immune functions [7].
Pathophysiology of the psychoneuroendocrine
axis
The presence of cellular receptors in the nervous, endo-
crine and immune systems allows the reception of infor-
mation from other systems via chemical messengers.
Under normal conditions, these three systems interact
to establish a homeostatic balance [4, 9] that promotes
adequate health and prepares the body for constant
struggle against various diseases. The loss of this balance
represents an interruption in the processes of interaction
among these four systems, resulting in the onset of
symptoms that characterize a pathogenic state. Many
factors, such as heredity, environment, personality traits,
emotions and lifestyles, influence these interactions.
Whether the stress generated by psychiatric disorders
such as depression and anxiety, behavior disorders, daily
hassles, and changes in the environment helps or im-
pairs the control of chronic inflammatory diseases re-
mains under debate. It is common to observe people
who thrive in environments or situations of high stress
as well as people whose health is negatively affected by
such stress [7].
Although no specific atopic personality profile has
been established, growing knowledge of the nervous sys-
tem supports new findings concerning the interaction
between neuroimmunological and epigenetic factors.
The skin and nervous system share a common origin:
the ectoderm. Any factor that plays a neurological role
can be observed in keratinocytes, fibroblasts, wandering
or resident cells (mast cells, Langerhans cells), or stem
or transient cells (lymphocytes, neutrophils and mono-
cytes) of the skin. Thus, primitive defense responses
such as inflammation and stress may modulate endo-
crine, dermatological and neurological responses [9, 10].
Stress modulates the immune response through the
psychoneuroimmunoendocrine pathway and the
hypothalamic-pituitary-adrenal axis [11] via the release
of cortisol, norepinephrine, epinephrine and interferon-
gamma (IFN-γ) by T lymphocytes. Increased levels of
proinflammatory cytokines such as IFN-γ (T helper cell
type 1 (Th1) cytokine) and a rapid but tissue-damaging
cellular immune response constitute the immune system
response [12]. Cortisol and catecholamines decrease the
production of tumor necrosis factor-alpha (TNF-α) by
antigen-presenting cells and promote Th2 responses via
the release of interleukin (IL)10, IL13 and IL4 [13]. This
process permits the immune system to halt acute re-
sponses but also favors allergic diseases [14, 15]. It has
recently been found that epigenetic factors encourage
the development of inadequate stress responses, paving
the way for a chronic stress response instead of an acute
stress response [10, 16, 17].
Table 1 shows a summary of different studies provid-
ing scientific relevance regarding the effect of stress on
the immune system.
Stress and the psychoneuroimmunoendocrine
axis
In 1936, the concept of general adaptation syndrome
and its phases of alarm, resistance and exhaustion in re-
sponse to an aggression were first proposed [5]. Cur-
rently, consensus continues to be sought concerning the
definition of stress, for which terms such as homeostatic
imbalance, a discrepancy between expectations and per-
ceptions of the environment, and allostasis are used.
Allostasis is the ability to maintain a stable internal en-
vironment despite the influence of external elements,
i.e., adaptation. Adaptation is not achieved when the
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Table 1 Relevant studies about the influence of psychological stress on the immune system
References Main conclusions
Ortega M. 2006 [90] Stress is a risk factor for health in all systems of the body; even though a certain level of stress is essential to
boost productivity, once a limit is exceeded by an intense stressor, the body becomes depleted, causing
stress-associated diseases.
Rosenthal S. 2002 [91]
Ray O. 2004 [92]
Sierra R et al. 2006 [93]
Sandín B. 2008 [94]
McEwen B.S. 2008 [95]
An altered immune system caused by stressful events increases the body’s vulnerability (to infectious diseases,
cancer and autoimmune diseases).
Borysenko J, Borysenko M. 1983 [96]
Gidron Y et al. 2003 [97]
Ho W, Evans D, Douglas S. 2002 [98]
Social, physical, and biological factors that cause stress may induce immunosuppression, including inability
to adapt to the environment, trauma, major surgical interventions, radiation, infection, and cancer.
Monjan A, Collector M. 1977 [99] Exposure to chronic stress induced proliferation of T and B lymphocytes similar to or to an even greater
than a control treatment. Additionally, exposure of mice to acute noise stress for more than 2 to 3 h a day
for fewer than 2 consecutive days reduced B and T lymphocyte proliferation in response to the mitogens
lipopolysaccharide and concanavalin A, compared to non-exposure to stress.
Fillion L et al. 1994 [100]
Weiss J et al. 1989 [101]
Hucklebridge F, Clow A, Evans P. 1998
[102]
Stress is related to increased viral retention in tissues, along with a decrease in the number of circulating
lymphocytes and in the mitogenic response in vitro. In addition, stress diminishes the activity of natural killer
(NK) cells, a powerful mechanism for the elimination of tumor cells and the production of interferon-γ.
Moynihan J, Ader R, Crota L et al. 1990
[103]
Most immune responses are suppressed by stress, but moderately intense stress conditions can increase them.
Croset G et al. 1987 [104] Rat immune system reactivity was tested by determining the proliferative response after mitogenic
stimulation in vitro as well as the capacity to generate a primary antibody response after immunization with
red blood cells from sheep. An increase in the immune response in vitro and in vivo was demonstrated
following exposure to a single shock. Thus, it was concluded that emotional stimuli facilitate immune
responses. However, when a rat was confronted with a conflict situation, there was a decrease in the
reactivity of the immune system. These findings led to the final conclusion that the immune system
specifically and immediately reacts to different psychological stimuli.
Shirinsky I, Shirinsky V. 2001 [105]
Belova T et al. 1988 [106]
Immune reaction initiation may be strongly affected by stress-induced cerebrovascular damage.
Churin A et al. 2003 [107] Immobilization stress induces different immune system reactions in distinct strains of rodents. These
reactions can be classified according to the intensity of the humoral immune response for thymus-dependent
antigens into categories such as high, moderate and low responders. High and moderate responders are
characterized by high sensitivity of the productive phase of the humoral immune response and the phagocytic
activity of macrophages. In low responders, stress only slightly affected the productive phase of the humoral
immune response, but peritoneal macrophage activity decreased. This evidence reflects the different reactions
of the immune system.
De Groot J et al. 2002 [108] This study of stress revealed the consequences of stress on the quality and quantity of immunological
memory in the long term. Mice were subjected to social stress after herpes simplex virus infection. Stressed
mice were shown to exhibit suppressed antibody response and impaired memory for the production of IL4
and IL10 as a specific response to the virus, whereas non-stressed mice showed intact immune responses
and immune memory.
Guayerbas N et al. 2002 [109] This study found that on standard behavioral tests, rodents with high levels of anxiety had less competition
in their immune system (premature immunosenescence), as demonstrated by certain functional alterations
of peritoneal macrophages, such as substrate adherence, chemotaxis, phagocytosis, and superoxide anion
production.
Zelena D et al. 2003 [110] In rats subjected to stress by repeated trapping, chronic stress signs including decreased thymus size and
weight, increased adrenal gland weight, and increased basal corticosterone levels were observed.
Molina P. 2001 [111] Studies in rats subjected to hemorrhagic shock stress showed a suppressive role of noradrenergic innervation in
the increase in tissue TNF-α levels initiated by hemorrhage in vivo. Therefore, it was concluded that norepinephrine
protects against tissue damage but may contribute to generalized immunosuppression following trauma.
Wonnacott K, Bonneau R. 2002 [112] In a murine model, stress reduced the ability of specific cytotoxic memory T lymphocytes to protect against
lethal intranasal or intravaginal infection with a herpes simplex virus. Stress also restricted the ability of these
lymphocytes to limit virus levels at the site of the infected mucosa.
Paltrinieri S et al. 2002 [113] The efficiency of granulocytes was studied in sheep subjected to acute stress, and the results demonstrated
that acute stress significantly increased the adhesion of these cells. This mechanism could be responsible for
the depression of innate immunity observed in stressed animals.
Sánchez M, Cruz C. 1991 [114] Human studies revealed that IgA class antibodies, which are important in the defense against viruses and
bacteria, had reduced abundance in individuals with a particular personality type.
González-Díaz et al. World Allergy Organization Journal  (2017) 10:19 Page 3 of 13
response is ineffective or inadequate or when exposure
to the agent that induces the response is prolonged,
resulting in allostatic load, which is defined as wear and
tear from the under- or overactivity of allostatic systems
[18]. Allostatic load is increased by an overreaction of
the adaptive mechanisms capable of generating a disease,
transforming a protective mechanism that maintains sys-
temic homeostasis when faced with an aggression into a
highly pathogenic mechanism with a prolonged effect.
Stress is defined as a real or interpreted threat to the
Table 1 Relevant studies about the influence of psychological stress on the immune system (Continued)
Stowell J. 2003 [115] In humans, certain academic examinations can have a noteworthy impact on mental and physical health.
Matalka K. 2003 [116] A review of mental stress models (short and written examinations as subacute and acute types of stressors)
was conducted to understand the effects of stress on the neuroendocrine and immune systems. In stressed
students, a short period (minutes) of preparation for a written exam induced the production of proinflammatory
cytokines, which could be related to a Th1 response. Nevertheless, prolonged mental stress (of several days)
caused deregulation of immune function, with a change in the cytokine response to a Th2 response.
Anyanwu E et al. 2003 [117] Abnormal NK cell activity was found in patients exposed to toxigenic materials, leading to adverse health
conditions, including a wide range of neuroimmune and behavioral consequences.
Ho C et al. 2001 [118] Measurable changes in dendritic cell abundance were observed in patients undergoing surgery. These cells
were rapidly mobilized in the circulation in response to surgical stress, and this activity may prepare host
immune defenses against trauma.
Woiciechowsky C et al. 1998 [119] In patients with sympathetic activation due to acute accidental brain trauma, rapid systemic release of the
anti-inflammatory cytokine IL10 from non-stimulated monocytes occurs. The rapid release of this cytokine
may signify a common pathway for stress-induced immunosuppression.
Dhabhar F, McEwen B. 1999 [120] Divergent from the concept that stress impairs immunity, human studies showed that short-term stressors
pointedly increase delayed hypersensitivity reactions of skin.
Glaser R. 2005 [121] Individuals exposed to chronic diseases are more likely to present deleterious health and hygiene habits
compared to individuals who do not have stress, such as sleep disturbances, malnutrition, physical inactivity
and drug and tobacco abuse; thus enhancing the adverse effects of stress on the immune system and
overall health.
Levitina E. 2001 [122] Immunological studies in infants who suffered from perinatal hypoxic stress demonstrated impaired cellular
immunity (lymphocyte subpopulations) and humoral immunity (immunoglobulin concentrations). Acute
hypoxia led to transient immunodeficiency due to stress.
Ramos, V et al. 2008 [123] Chronic and excessive stimulation of the hypothalamic-pituitary-adrenal axis induces the production of
glucocorticoids, the final products of this axis, altering the levels of white blood cells, decreasing the activity
of NK cells and inhibiting the production and secretion of ILs that are important in mediating the immune
response.
Mohr D, Pelletier D. 2004 [124] Stress in individuals with multiple sclerosis increases the permeability of the blood–brain barrier to immune
cells circulating in the blood. As a result, there is an increase in the infiltration of leukocytes into the CNS.
Selye H. 1936 [125] Hypotrophy of the thymus and lymph nodes was demonstrated after exposure to stress. The immunomodulatory
effect of glucocorticoids is essential to this effect.
Kay G et al. 1998 [126] Prenatal stress from maternal isolation and exposure to noise and intense light during the last week of
gestation in rats reduced the proliferative response of B lymphocytes and decreased the cytotoxic activity of
NK cells in peripheral blood.
Spitzer et al. 2010 [127] People diagnosed with post-traumatic stress disorder were found to be significantly more likely to have
elevated C-reactive protein levels.
Gill J, Page G 2008 [128]
Gola et al. 2013 [129]
Sutherland, A., Alexander, D.
Hutchison, J.2003 [130]
von Kanel et al. 2006 [131]
von Kanel et al. 2007 [132]
Baker et al. 2001 [133]
Maes et al. 1999 [134]
Newport D, Nemeroff C. 2000 [135]
Research showed that people with post-traumatic stress disorder have elevated levels of proinflammatory
cytokines, especially IL6, which has been considered a potential prognostic biomarker for this pathology.
Gotovac et al. 2010 [136]
Pace et al. 2012 [137]
Evidence was found for cytotoxic changes to NK cells in people with post-traumatic stress disorder, as well
as an increase in the number of glucocorticoid receptors on lymphocytes and a decrease in the sensitivity
to glucocorticoids.
Cohen et al. 2001 [138]
Herbert T, Cohen S. 1993 [139]
Reduced NK cell cytotoxicity, suppressed lymphocyte proliferative responses, and blunted humoral responses to
immunization were found in chronic stress models.
Montoro J et al. 2009 [140] Activation of the neuroendocrine and sympathetic nervous systems through catecholamine and cortisol
secretion influences the immune system, modifying the balance between Th1 and Th2 responses in favor of
the Th2 response.
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physiological or psychological integrity of an individual
that results in specific, physiological or behavioral re-
sponses seeking to restore homeostasis and whose
chronicity is potentially pathogenic [19]. Castrillón et al.
defined psychological stress as a pathophysiological
process that occurs when an individual is faced with en-
vironmental demands that exceed his or her resources,
inducing a response that involves physiological and cog-
nitive activation of the body (CNS, endocrine system
and immune system) in order to quickly and forcefully
meet the demands of the situation. Therefore, the re-
sponse to psychological stress is systemic in nature and
has several metabolic consequences, such as increased
steroid synthesis and a state of chronic inflammation [1].
The response of the body to stress involves the partici-
pation of different homeostatic regulatory systems, caus-
ing functional alterations that lead to chronic stress,
which forms the basis for the development of cardiovas-
cular, metabolic, immunologic, allergic, oncologic and
psychiatric disease. An individual’s response to stress is
provoked by genetic and psychological factors, which ex-
plains the large interindividual variability in the response
to similar stimuli [18]. Different stressors cause distinct
responses through the activation of specific neuroendo-
crine systems [19].
The following points are taken into account when
explaining pathophysiological stress: first, the emotional,
behavioral and physiological components of a stress re-
action are controlled by corticotropin-releasing hor-
mone; second, the intensity and duration of the reaction
of the hypothalamic-pituitary-adrenal axis to stress are
modulated by the release of glucocorticoids from the
hippocampus, which is very sensitive to hippocampal
neuronal activity and glucocorticoid insufficiency, and
variation in the effectiveness of the brake system for
hypothalamic-pituitary-adrenal axis activity likely ac-
counts for interindividual differences in stress responses;
and third, through a combination of cytokines and glu-
cocorticoids, the reciprocal interactions between the im-
mune system and the CNS constitute another regulatory
element, and altered function of these interactions can
be the origin of a pathology [20]. Chronic stress pro-
duces alterations in hippocampal neurons, resulting in
memory problems. Similarly, chronic stress can suppress
immune system defenses and produce a range of psy-
chophysiological symptoms such as adrenal fatigue
caused by reduced cortisol levels. Emotional distress has
a direct influence on inflammatory processes due to the
chronic upregulation of proinflammatory cytokines,
which are direct causes of respiratory allergies, rheuma-
toid arthritis, fibromyalgia, obesity, metabolic syndrome,
type 2 diabetes, cancer and cardiovascular diseases. In
addition, depression, insomnia, and chronic fatigue syn-
drome are caused by a reduction in cortisol levels [21].
Such diseases are the result of a continuous process of
multidirectional interactions among the frontal lobe of
the brain (which perceives stress), the autonomic ner-
vous system, the endocrine system and the immune sys-
tem [18]. A better understanding of the molecular actions
of cortisol in the processes of memory and learning or in
sleep disorders such as insomnia would facilitate progress
in the prevention and both pharmacological and psycho-
logical treatment of stress disorders for those who are pre-
disposed to such conditions [22]. Figure 1 shows the
impact of stress on the psychoneuroimmunoendocrine
axis.
Relationship of epigenetic factors with
psychoneuroimmunoendocrine factors
Epigenetics is the study of all non-genetic factors that
interfere in the determination of ontogeny or in the de-
velopment of an organism from fertilization to senes-
cence. Such factors are involved in the heritable
regulation of gene expression via methylation, acetyl-
ation and phosphorylation of DNA rather than alteration
of the nucleotide sequence. The concept of epigenetics
was coined by Conrad Waddington in 1953 and gained
importance after the human genome project in 2003 [23,
24]. Living in urban areas, resulting in greater exposure
to chemicals, reduced green spaces, and the consequent
limited presence of flora, fauna and microbial life, is as-
sociated with immune dysfunction in humans. Reduced
contact with nature and environmental microbiota ap-
pears to be related to a range of diseases including al-
lergy and type 1 diabetes [25, 26]. Alterations in
intestinal flora influence the development of not only
asthma and allergies but also other chronic and recur-
ring inflammatory disorders, such as type 1 diabetes, in-
flammatory bowel disease, obesity, and even psychiatric
disorders [27]. Epigenetics has transformed our under-
standing of the impact of the environment on our genes
and health, which in turn will potentially streamline
many lines of research in psychoneuroimmunology seek-
ing to explain how environmental cues are transduced
into the genome [28, 29]. In turn, the psychosocial envir-
onment can substantially change behavior and alter ner-
vous, endocrine and immune functions.
Allergic diseases and the
psychoneuroimmunoendocrine axis
A close relationship between allergic diseases and psy-
choneuroimmunoendocrinology exists [10, 30]. Stress
negatively impacts patient quality of life, leading to de-
velopment of depression, anxiety and unhealthy lifestyles
along with secondary problems such as overweight and
obesity, which negatively impact the control of atopic
diseases [6]. Studies support this association and urge
further investigation. A study of adolescents in the
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United States documented that atopic diseases such as
asthma, allergic rhinitis and atopic dermatitis correlate
with increased risk of anxiety and depression and that
this risk is further increased when asthma and allergic
rhinitis are concomitantly present [31]. Further research
found that depressive disorders are common in individ-
uals with asthma but that there is no correlation be-
tween the severity of asthma and the severity of
depression [32]. The quality of life of adolescent patients
with atopic dermatitis and underlying psychiatric disor-
ders was also assessed: a high prevalence of anxiety and
depression was found in these individuals. Studies have
shown a link between quality of life and sleep loss and
depression induced by atopic dermatitis [33]. Recently,
the association between allergic rhinitis and psychiatric
diseases such as depression and anxiety has been deter-
mined. In nine out of 11 studies, there was an associ-
ation between allergic rhinitis and anxiety, and in ten
out of 12 studies, there was an association of depressive
disorder with allergic rhinitis [34]. Patients with atten-
tion deficit/hyperactivity disorder have a higher inci-
dence of asthma, allergic rhinitis and atopic dermatitis
than the general population. Children with atopic dis-
eases are exposed to higher levels of inflammatory cyto-
kines that are released due to an allergic response, and
these cytokines can cross the blood–brain barrier and
activate neuroimmunological mechanisms involved in
emotions and behavior. Furthermore, activation in regions
of the prefrontal cortex, potentially due to exaggerated
and sustained release of inflammatory mediators, has been
found. Another possible hypothesis explaining the rela-
tionship between these two diseases is based on the
finding that allergic rhinitis is often associated with sleep
disturbance, which may cause symptoms of daytime fa-
tigue, inattention, irritability and impulsivity, which are in
turn components of clinical attention deficit/hyperactivity
disorder and its associated pathologies [35]. Urticaria oc-
curs frequently in patients with psychiatric problems and
emotional distress. Staubach P et al., found that 48 percent
of patients with chronic spontaneous urticaria have at
least one mental disorder; anxiety was the primary associ-
ated pathology, but depression and somatization disorders
were also found [33, 36].
There is a relationship between obesity and allergic
diseases. Adipokines, which are fat proteins that func-
tion as cytokines, chemokines and cytokine receptors
have an important role in that relationship. At present,
most studies on obesity, allergic diseases and asthma are
based on the inflammatory and metabolic roles of leptin
and adiponectin. Adiponectin is an anti-inflammatory
protein that inhibits IL6, the transcription factor NFκB
and TNF-α and that increases the concentration of IL1
and IL10. Adiponectin levels are decreased in obese
people due to necrosis of fat tissue resulting from hyp-
oxia, which causes infiltration of polymorphonuclear
cells and macrophages that secrete IL6 and TNF-α and
inhibit the synthesis of adiponectin [37]. Lectin is a pro-
inflammatory protein that promotes the release of IL6
and TNF-α, decreases the activity of regulatory T cells,
promotes Th1 lymphocyte activity and increases the
levels of IFN-γ [38, 39].
There is a strong positive association between asthma
incidence and lectin levels in prepubescent males and
postmenopausal women. Obesity reduces progesterone
Fig. 1 Stress and psychoneuroimmunoendocrinology axis. ANS: autonomic nervous system; HPA: hypothalamic-pituitary-adrenal; IL-6: interleukin
6; RAA: renin-angiotensin-aldosterone
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levels in women, which lowers the levels of β2 adrener-
gic receptors, decreasing the relaxation of muscle in the
respiratory tract [40]. The concentrations of both total
and specific IgE in children and adolescents with allergic
symptoms are higher among those who are overweight
or obese [41].
Vitamin D deficiency is more common in the obese
population, in whom there is an inverse relationship be-
tween serum vitamin D levels and the degree of obesity.
Vitamin D has also been shown to skew T cells toward a
less inflammatory state. For instance, 1,25(OH)2D3 de-
creases T cell-mediated IFN-γ production while increas-
ing IL4 production [42, 43]. Both the generation and
immunosuppressive capacity of Foxp3 + CD4+ regula-
tory T cells are increased by 1,25(OH)2D3 [44]. More-
over, recent studies showed that production of the
inflammatory cytokine IL17 by T cells is prevented by
1,25(OH)2D3 [43, 45]. In line with these results, other
groups have documented that the development of Th17
cells is negatively modulated by 1,25(OH)2D3 [46]. Pro-
duction of IL21, IL22 and IL17 is also inhibited by
physiologically relevant doses of 1,25(OH)2D3 in Th17-
skewed T cells; this evidence suggests that principal
changes in transcription are driven by the vitamin D
receptor-transcription factor complex [43].
At the same time, vitamin D deficiency is associated
with a decrease in immune cell proliferation as well as
synthesis of cytokines, including IL1, IL2, IL6 and IL12,
TNF-α and IFN-γ. These cytokines, which are upregu-
lated in patients with obesity and metabolic syndrome,
decrease the serum concentrations of vitamin D. Thus,
it has been presumed that in overweight patients, as the
amount of visceral adipose tissue increases, the kidnap-
ping of vitamin D by adipose tissue increases. Secondar-
ily, it is proposed that vitamin D deficiency or
insufficiency is responsible for insulin resistance and
thereby promotes metabolic syndrome [47]. Vitamin D
deficiency has been associated with increased airway
hyperresponsiveness, decreased lung function, reduced
asthma control, and resistance to steroids [48]. A re-
cently conducted study of treated asthmatic children
showed that 84.2% of children with asthma had low
levels of vitamin D. In that study, overweight was an im-
portant risk factor for vitamin D deficiency and insuffi-
ciency [49]. Another study found that vitamin D
deficiency is associated with an increased risk of severe
asthma in asthmatic adults (odds ratio [OR], 5.04; 95%
confidence interval [CI]: 1.23 to 20.72; p = 0.02) and that
high levels of vitamin D are related to a lower risk of
hospitalization or emergency department visitation in
the past year (OR, 0.90; 95% CI, 0.84 to 0.98; p = 0.04)
[50]. Obesity and overweight have also been associated
with increased residual capacity and increased risk of
asthma. It has been observed that children with asthma
are at an increased risk of exacerbations as well as un-
controlled asthma [51, 52]. It has also been shown that
there is an association between low vitamin D levels,
physical inactivity and high BMI [53]. Alternatively, vita-
min D may reduce asthma severity and improve asthma
control [54].
The psychoneuroimmunoendocrine axis and its
relationship to other relevant diseases
Based on the pathophysiological mechanisms described
above, the psychoneuroimmunoendocrine axis has been
related to neuropsychiatric diseases such as depression
[4, 55–57] and schizophrenia [56, 58–61], metabolic syn-
drome [62, 63], rheumatologic and autoimmune diseases
[64–72], irritable bowel syndrome [73, 74], periodontal
disease [75, 76] and neoplastic diseases [62, 77], and
these relationships warrant significant attention. Psycho-
neuroimmunology represents the challenge of health
professionals to achieve multidisciplinary management
of each of these pathologies.
Psychoneuroimmunology and the naturalistic
model
We propose a new medical model that has been de-
scribed to be based on the concept of holistic medicine,
in which biological, psychological, social and environ-
mental aspects of the health-disease process are taken
into account in the recommendation of a revised life-
style. Through allostasis, the autonomic nervous system,
the hypothalamic-pituitary-adrenal axis, the cardiovascu-
lar system, the immune system, the endocrine system
and metabolism protect the body by preparing these sys-
tems to address both internal and external stress. This
concept of allostasis complements the concept of stress.
Allostasis represents the active adaptation process in-
volving the production of mediators such as adrenal ste-
roids, catecholamines, cytokines, neurotransmitters and
other factors. After suffering chronic stress, adaptation
responses or allostatic responses are initiated in the
body. Inadequate or excessive responses following re-
peated stressful situations lead to allostatic load, which
is the “price paid by the organism” for being forced to
adapt to psychosocial or physical adversity. Thus, allo-
static load constitutes the cumulative wear and tear
resulting from chronic hyperactivity as an adaptation to
the constant demands of life. The response to stress is
physical, mental and behavioral and depends on basic
personality as well as social, cultural, environmental
and genetic factors. A new medical paradigm of health
promotion and disease prevention is very important, as
this paradigm supports lifestyle changes that increase
resilience to stress and augment immune system de-
fenses [78].
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Psychoneuroimmunology, education and stress
management strategies
Health education must consider the need to educate
people regarding their potential and shortcomings in as-
suming their own identity. Another contribution of
health education is to orient people regarding the man-
agement of emotions in order to facilitate the appropri-
ate channeling and expression of emotions, which is a
form of disease prevention and, consequently, a reflec-
tion of health and wellbeing.
The discipline of health education has the major chal-
lenge of establishing principles and methodologies that
enable people to learn healthy practices and lifestyles so
as to enhance their capacity for resilience. In addition,
health education seeks to develop and promote the
process of addressing struggles or mishaps of life and of
resisting, overcoming and transforming adversity in
order to emerge strengthened or even renewed. The de-
velopment of fundamental strategies for the prevention
of disease and the recovery of health through health
education interventions results in positive adaptation in
contexts of great adversity. In addition, health education
interventions should help people learn to take measures
that enhance their ability to combat disease and that
properly harmonize and balance mind-body function.
Health promotion strategies should be directed toward
prevention and resolution of health problems and to-
ward improving quality of life [79].
As mentioned above, lifestyle changes that increase re-
silience to stress and enhance immune system defenses
are indispensable. Adequate daily rest; a diet that de-
creases oxidative stress, including daily consumption of
fruits, vegetables, legumes, essential fatty acids and trace
elements; and physical exercises that activate the immune
system, such as breathing exercises that increase breathing
capacity, and elimination of cigarette, drug and alcohol
use are among the lifestyle changes to be considered. In
addition, focusing on psychological aspects such as tracing
life goals, being flexible, maintaining harmonious commu-
nication with others, having a consistent attitude in life,
optimism and proper management of emotions, can also
help with stress management [80].
Diet appears to play an important role in stress man-
agement. Relations of multivitamins and minerals with
stress have been described: the main identified antistress
drugs contain vitamins E, B1, B2, B3, B5, B6, B12, and C,
folic acid and the minerals zinc and iron [81]. Omega-3
fatty acids are very important for the functioning of the
human brain. Poor intake of these acids induces several
alterations in neurotransmission that can cause diverse
psychiatric disorders, including schizophrenia and major
depression. It has been observed that patients with psychi-
atric disorders who use fatty acid supplements exhibit a
significant improvement in their symptoms. In addition,
omega-3 fatty acids have been shown to be useful in de-
creasing antisocial behavior, hostility and aggressiveness in
patients who are exposed to a psychologically stressful en-
vironment. Therefore, supplements containing omega-3
fatty acids can reduce such behaviors [82].
Exercise can be an effective stress management strat-
egy and should be recommended for addressing acute,
episodic acute, and chronic stress. One advantage of in-
corporating exercise with other stress management tech-
niques is the psychological and physical beneficial effects
of exercise. However, it is important to remember that
exercise is only one component of a stress management
program. Even though exercise may be effective in help-
ing a person feel calmer, this change will not resolve the
main triggers of chronic stress. It may be necessary to
refer people suffering from chronic stress to profes-
sionals who can help them cope with their stressors [83].
Research on exercise and stress has typically focused on
aerobic exercise. For instance, it has been reported that
patients feel calmer after 20 to 30 min of aerobic exer-
cise and that the calming effect of exercise can last for
several hours afterwards. Recently, there has been an in-
crease in the amount of research examining the role of
body-mind types of exercise, such as yoga and Tai Chi in
reducing stress. Nevertheless, there is limited research
on the role of resistance exercise in managing stress
[83]. Studies of humans and animal models have shown
that being physically active improves the ability of the
body to handle stress due to changes in hormonal re-
sponses and that exercise results in actions of brain neu-
rotransmitters, such as dopamine and serotonin, that
affect the body, state of mind and behavior. Additionally,
exercise may serve as a time away or release from
stressors. In a study of women attending a university
who reported that studying was their main stressor, per-
forming a constant exercise activity without performing
a study activity and resting while exercising had a
greater calming effect than quiet rest [84]. Recent publi-
cations on yoga or Tai Chi indicate that these types of
mental exercise can be effective in reducing stress. Au-
thors have suggested that the results should be viewed
with caution because the quality of the studies varied
[85, 86]. The decrease in stress reported in one review
was similar to or greater than the reduction in other
types of commonly used stress management strategies
[87]. Lack of time is the limitation to performing exercise
most commonly expressed by individuals. Lack of motiv-
ation, tiredness, and poor sleep and eating habits are add-
itional factors associated with stress that can negatively
affect compliance with an exercise regime [88].
Acupuncture may be effective in the treatment of
chronic stress symptoms [89]. The main investigative
findings concerning the effects of acupuncture on stress
are outlined in Table 2.
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Mindfulness, a new therapeutic model proposed for
the management of chronic stress, consists of an individ-
ual’s awareness of and attention to his or her symptoms
of emotional distress experienced under chronic stress.
This strategy facilitates therapies and enables the modifi-
cations necessary to improve lifestyle. This intervention
is practiced by Manolete S. Moscoso at the University of
South Florida. The purpose of this therapeutic interven-
tion program is to instruct the individual in the relax-
ation response, reduce the level of chronic stress and
change patterns of self-destructive behavior, obtaining
an immune and neuroendocrine benefit that promotes
the restoration of health and helps control the symp-
toms caused by medical treatments, which allows pa-
tients experiencing severe depression to counter the
recurrence of this disease. Mindfulness allows focus and
consciousness in the body through breathing, in the
mind through thought, and the environment through
the senses. The belief of “living on the run” from stress
and emotional pain through daily life experiences con-
tributes to fear, tension, anxiety, worry, anger and hostil-
ity. When behavior is modified in response to the
difficulties of life and when it is understood that pain
and pleasure are genuinely human experiences, an indi-
vidual can achieve an adequate level of acceptance and
peace [18, 62].
Conclusions
Diseases are the result of an alteration at the bio-
psycho-social level that can indicate lifestyle changes
that should be made in addition to appropriate medical
management and treatment. Emotions and stress
significantly affect health and one’s susceptibility to a
pathology, as well as one’s ability to recover from an ill-
ness. Psychoneuroimmunology should provide know-
ledge about the biological dynamics of conventional and
alternative medicines for fighting disease. The psycho-
neuroimmunological axis comprises several disease-
producing mechanisms in which different disciplines of
medicine interact, implying the need for an integrative
approach. The science of psychoneuroimmunology must
go hand in hand with health education and the promo-
tion of healthy lifestyles in order to attain patient health.
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relaxation, and deactivates the analytical brain, which is responsible for anxiety.
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reactivity in the hippocampus.
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dopamine, neuropeptide Y and ACTH, thus altering the mood chemistry of the brain to help combat
negative affective states.
Arranz L, Guayerbas N, Siboni L et al. (2007) [151] Acupuncture reverses pathological changes in levels of inflammatory cytokines that are associated
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Kavoussi B, Ross B. (2007) [152] Acupuncture reduces inflammation by promoting the release of vascular and immunomodulatory
factors.
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